Published in Acta Obstet Gynecol Scand on October 01, 2002
Effect of Fee on Attendance in Cervical Cancer Screening | NCT02378324
Immigrant women's experiences and views on the prevention of cervical cancer: a qualitative study. Health Expect (2012) 0.97
Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial. BMJ Open (2012) 0.91
Cervical cancer in the screening era: who fell victim in spite of successful screening programs? J Gynecol Oncol (2011) 0.90
Perception of women on cancer screening and sexual behavior in a rural area, Jamaica: Is there a public health problem? N Am J Med Sci (2010) 0.82
Correlates of women's cancer screening and contraceptive knowledge among female emergency department patients. BMC Womens Health (2007) 0.78
When Life Got in the Way: How Danish and Norwegian Immigrant Women in Sweden Reason about Cervical Screening and Why They Postpone Attendance. PLoS One (2015) 0.77
Avoiding piecemeal research on participation in cervical cancer screening: the advantages of a social identity framework. Health Expect (2012) 0.77
Does the primary screening test influence women's anxiety and intention to screen for cervical cancer? A randomized survey of Norwegian women. BMC Public Health (2014) 0.75
Decision making for Pap testing among Pacific Islander women. Health Educ Res (2016) 0.75
How does HPV vaccination status relate to risk perceptions and intention to participate in cervical screening? a survey study. BMC Public Health (2016) 0.75
Effects of numerical information on intention to participate in cervical screening among women offered HPV vaccination: a randomised study. Scand J Prim Health Care (2016) 0.75
Effect of Fee on Cervical Cancer Screening Attendance-ScreenFee, a Swedish Population-Based Randomised Trial. PLoS One (2016) 0.75
Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol (2006) 7.13
Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int (2011) 3.28
Advanced maternal age and adverse perinatal outcome. Obstet Gynecol (2004) 3.01
Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States. Eur Urol (2011) 2.81
The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int (2009) 2.63
Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol (2008) 2.41
Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Eur Urol (2009) 2.33
National community prevalence of overactive bladder in the United States stratified by sex and age. Urology (2011) 2.18
Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study. BMJ (2007) 1.97
Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial. Eur Urol (2012) 1.95
Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. Contraception (2006) 1.90
A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women. Eur Urol (2009) 1.86
Influence of smoking, coffee, and tea consumption on bladder pain syndrome in female twins. Urology (2011) 1.59
A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century. Menopause (2002) 1.57
Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int (2006) 1.50
Design and validation of a new screening instrument for lower urinary tract dysfunction: the bladder control self-assessment questionnaire (B-SAQ). Eur Urol (2006) 1.43
The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS. BJU Int (2009) 1.40
The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS. BJU Int (2011) 1.38
Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women. Am J Obstet Gynecol (2003) 1.37
Economic burden of urgency urinary incontinence in the United States: a systematic review. J Manag Care Pharm (2014) 1.36
The economic impact of overactive bladder syndrome in six Western countries. BJU Int (2009) 1.29
Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45-103 years. Eur Urol (2010) 1.20
Hormonal contraception and venous thromboembolism. Acta Obstet Gynecol Scand (2012) 1.20
Understanding the elements of overactive bladder: questions raised by the EPIC study. BJU Int (2008) 1.12
Women's experience of coping with a positive Pap smear: A register-based study of women with two consecutive Pap smears reported as CIN 1. Acta Obstet Gynecol Scand (2003) 1.12
Evidence for a secular trend in menopausal age: a population study of women in Gothenburg. Menopause (2003) 1.12
A review of adherence to drug therapy in patients with overactive bladder. BJU Int (2008) 1.06
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstet Gynecol Scand (2002) 1.06
The current and future burden and cost of overactive bladder in five European countries. Eur Urol (2006) 1.06
Dynamic progression of overactive bladder and urinary incontinence symptoms: a systematic review. Eur Urol (2010) 1.04
Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer (2013) 1.03
The prevalence of chronic constipation and faecal incontinence among men and women with symptoms of overactive bladder. BJU Int (2011) 1.03
Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study. Cancer (2007) 0.99
Overactive bladder syndrome in older people. BJU Int (2007) 0.99
Overactive bladder: Is there a link to the metabolic syndrome in men? Neurourol Urodyn (2010) 0.98
Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial. Int J Cancer (2013) 0.98
Overactive bladder is associated with erectile dysfunction and reduced sexual quality of life in men. J Sex Med (2008) 0.95
Does HPV-status 6-12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence? Eur J Cancer (2007) 0.95
Oestrogens and overactive bladder. Neurourol Urodyn (2013) 0.94
UR-CHOICE: can we provide mothers-to-be with information about the risk of future pelvic floor dysfunction? Int Urogynecol J (2014) 0.93
The performance of a new scoring system for colposcopy in detecting high-grade dysplasia in the uterine cervix. Acta Obstet Gynecol Scand (2005) 0.93
The relationship between BMI and urinary incontinence subgroups: results from EpiLUTS. Neurourol Urodyn (2013) 0.93
Can we prevent incontinence? ICI-RS 2011. Neurourol Urodyn (2012) 0.91
Rationale for the study methods and design of the epidemiology of lower urinary tract symptoms (EpiLUTS) study. BJU Int (2009) 0.90
Genetics and the lower urinary tract. Neurourol Urodyn (2010) 0.90
Short- and long-term results of the tension-free vaginal tape procedure in the treatment of female urinary incontinence. Acta Obstet Gynecol Scand (2006) 0.90
Risk of urinary incontinence symptoms in oral contraceptive users: a national cohort study from the Swedish Twin Register. Fertil Steril (2008) 0.89
Examining lower urinary tract symptom constellations using cluster analysis. BJU Int (2008) 0.88
Contraceptive use and pregnancy outcome in three generations of Swedish female teenagers from the same urban population. Contraception (2009) 0.87
Expectant management of first-trimester miscarriage in clinical practice. Acta Obstet Gynecol Scand (2003) 0.86
The effect of combined oral contraceptives and age on dysmenorrhoea: an epidemiological study. Hum Reprod (2012) 0.86
The long-term influence of combined oral contraceptives on body weight. Hum Reprod (2011) 0.85
Genetic influences are important for most but not all lower urinary tract symptoms: a population-based survey in a cohort of adult Swedish twins. Eur Urol (2011) 0.85
Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL. Contraception (2007) 0.85
Low persistence of anticholinergic drug use in Sweden. Eur J Clin Pharmacol (2011) 0.85
The genetic and environmental contribution to the occurrence of bladder pain syndrome: an empirical approach in a nationwide population sample. Eur Urol (2010) 0.83
The impact of OAB on sexual health in men and women: results from EpiLUTS. J Sex Med (2011) 0.83
Lower urinary tract symptoms: lack of change in prevalence and help-seeking behaviour in two population-based surveys of women in 1991 and 2007. BJU Int (2009) 0.83
Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval. Acta Obstet Gynecol Scand (2005) 0.81
A randomized trial of basing treatment on human papillomavirus and/or cytology results in low-grade cervical lesion triage. Am J Obstet Gynecol (2008) 0.81
Maternal fatalities, fetal and neonatal deaths related to motor vehicle crashes during pregnancy: a national population-based study. Acta Obstet Gynecol Scand (2008) 0.81
The influence of the modifiable life-style factors body mass index and smoking on the outcome of mid-urethral sling procedures for female urinary incontinence. Int Urogynecol J (2015) 0.80
Faecal incontinence 20 years after one birth: a comparison between vaginal delivery and caesarean section. Int Urogynecol J (2014) 0.79
The influence of intrauterine contraception on the prevalence and severity of dysmenorrhea: a longitudinal population study. Hum Reprod (2013) 0.78
Impact of recent studies on attitudes and use of hormone therapy among Scandinavian gynaecologists. Acta Obstet Gynecol Scand (2007) 0.78
[Increasing number of Chlamydia infections--how can we reverse this trend?]. Lakartidningen (2002) 0.78
A longitudinal study of contraception and pregnancies in the same women followed for a quarter of a century. Hum Reprod (2010) 0.78
Moving towards a comprehensive assessment of lower urinary tract symptoms (LUTS). Neurourol Urodyn (2012) 0.78
Can we predict and prevent pelvic floor dysfunction? Int Urogynecol J (2015) 0.77
Clustering of pelvic floor disorders 20 years after one vaginal or one cesarean birth. Int Urogynecol J (2015) 0.77
Effects of estrogen plus progesterone on hemodynamic and vascular reactivity in hypertensive postmenopausal women. Blood Press (2010) 0.76
Cervical cancer screening--"For better or worse...": women's experience of screening. Cancer Nurs (2006) 0.76
Comparison of health care costs for open Burch colposuspension, laparoscopic colposuspension and tension-free vaginal tape in the treatment of female urinary incontinence. Neurourol Urodyn (2007) 0.75
Editorial comment. Urology (2010) 0.75
Acute effects of transdermal 17beta-estradiol on hemostatic variables after 24-hour treatment. Clin Appl Thromb Hemost (2002) 0.75
A focus on important reproductive health care issues - cancer, urinary incontinence and the consequences of pre-term birth. Acta Obstet Gynecol Scand (2010) 0.75
Influence of age and changes over time on erectile dysfunction: results from two large cross-sectional surveys 11 years apart. Scand J Urol (2012) 0.75
[Increasing number of teenage pregnancies--multicultural approach in the preventive work is needed]. Lakartidningen (2003) 0.75
The uterine cervix and the importance of cervical secretions. Acta Obstet Gynecol Scand (2009) 0.75
Maternal birth trauma: why should it matter to urogynaecologists? Curr Opin Obstet Gynecol (2016) 0.75
The cervical cancer screening program from a midwife's perspective. Acta Obstet Gynecol Scand (2007) 0.75
Influence of chronic hormone replacement therapy on left ventricular mass and serum-ACE activity. Blood Press (2010) 0.75
A three-armed randomized trial comparing open Burch colposuspension using sutures with laparoscopic colposuspension using sutures and laparoscopic colposuspension using mesh and staples in women with stress urinary incontinence. Acta Obstet Gynecol Scand (2005) 0.75